CClinicalTrials.gg
Not yet recruitingNCT07156981Updated Sep 5, 2025

Effects of Physiotherapy in Children With Hirschsprung's Disease

An interventional study of Physiotherapy in Hirschsprung Disease, sponsored by Ankara Yildirim Beyazıt University. Not yet recruiting. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-09-05.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
5 Years to 18 Years
Sex
All
01

Study summary

The aim of our study is to investigate the effects of physiotherapy in children with Hirschsprung's disease who have bowel symptoms after surgery.

Read the detailed description

Hirschsprung's disease is a developmental disorder of the enteric nervous system characterized by the absence of ganglion cells in the distal intestine, resulting in functional intestinal obstruction. The treatment applied after diagnosis is surgical. Although individuals with a history of surgery due to Hirschsprung's disease generally have normal bowel and urinary function, it has been reported that they have a higher prevalence of fecal incontinence and constipation and a lower quality of life related to the gastrointestinal system. However, there are few studies evaluating the use of physiotherapy in the management of postoperative bowel symptoms in children with Hirschsprung's disease.

02

Conditions studied

  • Hirschsprung Disease

Browse trials for

03

In context

Hirschsprung Disease

66 studies on the registry are indexed under Hirschsprung Disease; 23 are open to participants now.

This study's planned enrollment of 20 is below the median of 50 across 34 interventional studies indexed under Hirschsprung Disease.

Browse Hirschsprung Disease studies →

Lead sponsor

Ankara Yildirim Beyazıt University is the lead sponsor of 229 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children aged 5-18 who have undergone surgery for Hirschsprung's disease and have intestinal symptoms, and who come for routine check-ups.
  • Volunteering to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Presence of a congenital and/or chronic disease
  • Those with missing assessment parameters
  • Having a history of any additional orthopedic, neurological or psychiatric disease that will affect the evaluation parameters
  • Loss of sensation
  • Mental retardation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Physiotherapy

    Physiotherapy program will be performed

    Behavioral: Physiotherapy

Interventions

  • BehavioralPhysiotherapy

    The treatment program will include patient education, lifestyle recommendations, breathing exercises, pelvic floor muscle training, and stabilization exercises. The treatment program will last for a total of 8 weeks.

06

What researchers measure

Primary outcomes

  1. Bowel function

    Bowel function will be evaluated with a bowel diary. They will be asked to keep a bowel diary for 1 week, including the number and type of daily stools and the number of incontinent stools.

    Time frame: before and after treatment (8-week change)

Secondary outcomes

  1. Constipation

    Children's constipation will be evaluated with the Rome IV criteria. These criteria include; two or less defecation per week, fecal incontinence at least once a week, history of holding/ delaying the large toilet, painful and difficult bowel movements, presence of large feces in the rectum, presence of a history of large feces that can block the toilet. An increase in the number of symptoms indicates the severity of constipation.

    Time frame: before and after treatment (8-week change)

  2. Pelvic floor muscle function

    Pelvic floor muscle function will be evaluated with palpation form anus. The presence of correct contraction and relaxation of the pelvic floor muscle will be determined.

    Time frame: before and after treatment (8-week change)

  3. Life quality

    Life quality will be assessed with the Pediatric Quality of Life Inventory (PedsQL). The PedsQL consists of 23 items. It are scored between 0-100. The higher the total score of the life quality, the better health-related life quality is perceived.

    Time frame: before and after treatment (8-week change)

  4. Perception of improvement

    Subjective perception of improvement will be assessed as -1 (worse), 0 (no change) and 1 (better).

    Time frame: after treatment (8-week change)

  5. Compliance with recommendations

    Compliance with post-treatment recommendations will be assessed with the Visual Analog Scale (VAS). The VAS is a horizontal line with "0" at one end as "never compliance" and '10' at the other end as "always compliance".

    Time frame: after treatment (8-week change)

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07156981
Lead sponsor
Ankara Yildirim Beyazıt University
Responsible party
seyda toprak celenay (Professor, Ankara Yildirim Beyazıt University) — Principal investigator
First posted
Sep 5, 2025
Start date
Sep 30, 2025 (estimated)
Primary completion
Nov 30, 2025 (estimated)
Completion
Jan 30, 2026 (estimated)
Last update
Sep 5, 2025

Study contacts

Seyda Toprak Celenay
Contact
sydtoprak@hotmail.com
+90 312 906 1000
Seyda Toprak Celenay
principal investigator · Ankara Yildirim Beyazıt University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion